Mifepristone, misoprostol

DRUG5 trials

Sponsors

Gynuity Health Projects, University of Pittsburgh

Conditions

Abortion, InducedComplete AbortionInduced Abortion

Phase 2

Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation

CompletedNCT00330993

University of PittsburghAbortion, Induced

Start: 2006-03-31End: 2006-08-31Target: 120Updated: 2007-01-25

Unknown Phase

Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation

CompletedNCT00286208

Gynuity Health ProjectsInduced Abortion

Start: 2005-08-31End: 2008-01-31Updated: 2014-02-19

Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days Gestation

CompletedNCT00482209

Gynuity Health ProjectsInduced Abortion

Start: 2007-05-31End: 2009-10-31Target: 1220Updated: 2009-10-12

Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days Gestation

CompletedNCT00482209

Gynuity Health ProjectsInduced Abortion

Start: 2007-05-31End: 2009-10-31Target: 1220Updated: 2009-10-12

Expansion Study of a Simplified Regimen of Medical Abortion Thru 63 Last Menstrual Period (LMP) in Tunisia

CompletedNCT01173003

Gynuity Health ProjectsInduced Abortion

Start: 2009-06-30End: 2011-12-31Updated: 2014-02-19

Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days' Gestation in Kazakhstan

CompletedNCT02018796

Gynuity Health ProjectsComplete Abortion

Start: 2013-10-31End: 2014-12-31Updated: 2015-08-13

Related Papers

Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10 weeks of pregnancy in Kazakhstan

International Journal of Gynecology & Obstetrics2016-05-2620 citations